10 research outputs found

    Analisis Kesiapan Implementasi Badan Layanan Umum Daerah Puskesmas Kota Semarang (Studi Kasus pada Puskesmas Ngesrep dan Bandarharjo)

    Full text link
    Community Health Center as a public service agencies on health are requied to provide excellent service to community. However, still not met society's expectations due to complexity of flow budgeting. Implementation of the Local Public Service Agency (BLUD) is proposed solution for the problems with these flexibility to improve the service quality. All of Community Health Center in Semarang will Implement BLUD. The purpose of this study is to determine the readiness of the health center in BLUD Implementation case study in health centers community Ngesrep and Bandarharjo. The approach of this research is a qualitative descriptive. Data of this research were collected by in-depth interviews. The main informants numbered 4 are head of the community health center and head of administration with the triangulans numbered 5, are the treasurer and technical staff at both community health center and escort team of BLUD from Semarang Health Departement. the result of this research, Ngesrep and Bandarharjo Community Health Center is not ready to implement BLUD. It seen from lack of educational competences and lack number of staff because have no administrative personnel to implement BLUD and lack of infrastructure. The documents and requirement available as well, targets to be BLUD are good enough. Lack of communication and coordination. Executor Characteristics has support enough. Environment of social, economics, and politics is good, but there has no governing policy to regulate BLUD in municipal level. Executor Disposition is good it seen from Community Health Center Commitment and positive staffs attitude towards BLUD, but understanding and involvement of staff towards BLUD is still lack. The research suggest is to improve the understanding and qualification of staff and addition of administrative personnel for implementation of BLUD. Increase the intensity information of BLUD, making BLUD technical regulations on municipal level and improve the communication and coordination between community health center and Semarang health department

    HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality

    Get PDF
    Background Hepatitis C virus (HCV) is a leading cause of chronic liver disease, end-stage cirrhosis, and liver cancer, but little is known about the burden of disease caused by the virus. We summarised burden of disease data presently available for Europe, compared the data to current expert estimates, and identified areas in which better data are needed. Methods Literature and international health databases were systematically searched for HCV-specific burden of disease data, including incidence, prevalence, mortality, disability-adjusted life-years (DALYs), and liver transplantation. Data were collected for the WHO European region with emphasis on 22 countries. If HCV-specific data were unavailable, these were calculated via HCV-attributable fractions. Results HCV-specific burden of disease data for Europe are scarce. Incidence data provided by national surveillance are not fully comparable and need to be standardised. HCV prevalence data are often inconclusive. According to available data, an estimated 7.3–8.8 million people (1.1–1.3%) are infected in our 22 focus countries. HCV-specific mortality, DALY, and transplantation data are unavailable. Estimations via HCV-attributable fractions indicate that HCV caused more than 86000 deaths and 1.2 million DALYs in the WHO European region in 2002. Most of the DALYs (95%) were accumulated by patients in preventable disease stages. About one-quarter of the liver transplants performed in 25 European countries in 2004 were attributable to HCV. Conclusion Our results indicate that hepatitis C is a major health problem and highlight the importance of timely antiviral treatment. However, data on the burden of disease of hepatitis C in Europe are scarce, outdated or inconclusive, which indicates that hepatitis C is still a neglected disease in many countries. What is needed are public awareness, co-ordinated action plans, and better data. European physicians should be aware that many infections are still undetected, provide timely testing and antiviral treatment, and avoid iatrogenic transmission

    Rheumatoid arthritis - clinical aspects: 134. Predictors of Joint Damage in South Africans with Rheumatoid Arthritis

    Get PDF
    Background: Rheumatoid arthritis (RA) causes progressive joint damage and functional disability. Studies on factors affecting joint damage as clinical outcome are lacking in Africa. The aim of the present study was to identify predictors of joint damage in adult South Africans with established RA. Methods: A cross-sectional study of 100 black patients with RA of >5 years were assessed for joint damage using a validated clinical method, the RA articular damage (RAAD) score. Potential predictors of joint damage that were documented included socio-demographics, smoking, body mass index (BMI), disease duration, delay in disease modifying antirheumatic drug (DMARD) initiation, global disease activity as measured by the disease activity score (DAS28), erythrocyte sedimentation rate (ESR), C reactive protein (CRP), and autoantibody status. The predictive value of variables was assessed by univariate and stepwise multivariate regression analyses. A p value <0.05 was considered significant. Results: The mean (SD) age was 56 (9.8) years, disease duration 17.5 (8.5) years, educational level 7.5 (3.5) years and DMARD lag was 9 (8.8) years. Female to male ratio was 10:1. The mean (SD) DAS28 was 4.9 (1.5) and total RAAD score was 28.3 (12.8). The mean (SD) BMI was 27.2 kg/m2 (6.2) and 93% of patients were rheumatoid factor (RF) positive. More than 90% of patients received between 2 to 3 DMARDs. Significant univariate predictors of a poor RAAD score were increasing age (p = 0.001), lower education level (p = 0.019), longer disease duration (p < 0.001), longer DMARD lag (p = 0.014), lower BMI (p = 0.025), high RF titre (p < 0.001) and high ESR (p = 0.008). The multivariate regression analysis showed that the only independent significant predictors of a higher mean RAAD score were older age at disease onset (p = 0.04), disease duration (p < 0.001) and RF titre (p < 0.001). There was also a negative association between BMI and the mean total RAAD score (p = 0.049). Conclusions: Patients with longstanding established RA have more severe irreversible joint damage as measured by the clinical RAAD score, contrary to other studies in Africa. This is largely reflected by a delay in the initiation of early effective treatment. Independent of disease duration, older age at disease onset and a higher RF titre are strongly associated with more joint damage. The inverse association between BMI and articular damage in RA has been observed in several studies using radiographic damage scores. The mechanisms underlying this paradoxical association are still widely unknown but adipokines have recently been suggested to play a role. Disclosure statement: C.I. has received a research grant from the Connective Tissue Diseases Research Fund, University of the Witwatersrand. All other authors have declared no conflicts of interes
    corecore